CLDN1 and infection: In AD patients, reduced expression of claudin-1 (CLDN1) and other TJ components correlates with higher TEWL and increased susceptibility to infections; experimental manipulation of CLDN1 in models supports its causal role in inflammation and barrier dysfunction [127,128,129].